Early research (Phase 1)Study completedNCT01682902
What this trial is testing
A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes
Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 43